Na nso nso a, Nantong Chanyoo emela ihe dị ịrịba ama ọzọ na akụkọ ntolite!Site na mbọ a gbara ihe karịrị otu afọ, KDMF mbụ nke Chanyoo enwetala nkwado nke MFDS.Dị ka onye na-emepụta Calcium Rosuvastatin na China.anyị chọrọ imeghe isiakwụkwọ ọhụrụ na ahịa Korea.A ga-ewepụtakwa ngwaahịa ndị ọzọ n'ime afọ ole na ole sochirinụ.

Ọzọkwa, ị nwere ike zoo aka wee chọta ozi anyị na webụsaịtị a:

https://nedrug.mfds.go.kr/pbp/CCBAC03

Calcium Rosuvastatin dabara adaba maka ọgwụgwọ adjuvant nke ndị ọrịa nwere hypercholesterolemia mbụ (ụdị IIa, gụnyere heterozygous familial hypercholesterolemia) ma ọ bụ agwakọta lipemia (ụdị IIb) mgbe nri ma ọ bụ mmega ahụ adịghị mma.calcium rosuvastatinbụ 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor nhọrọ.Site na igbochi HMG-CoA reductase, ọ na-ebelata njikọ sel imeju na nchekwa nke cholesterol, si otú a na-ebelata mkpokọta cholesterol (TC) na ọkwa lipoprotein dị ala (LDL-C).

Dị ka data Newport si kwuo, site na June 30, 2018 ruo June 30, 2019, ire ere zuru ụwa ọnụ nke nkwadebe calcium rosuvastatin bụ ijeri US $ 3.461, mbelata kwa afọ nke 13%;ire ngwaahịa calcium rosuvastatin zuru ụwa ọnụ bụ tọn 151.09, mmụba kwa afọ nke 14%

Anyị,Ụlọ ọrụ ọgwụ Changzhou(onye nrụpụta enyemaka: Nantong Chanyoo Pharmatech Co., Ltd.) rara onwe anyị nye ndị na-ebubata Rosuvastatin API.